SCHEMBL7137336

SCHEMBL7137336

Cc1ccc(S(N)(=O)=O)cc1C(C)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.48
POLB P06746 1/20 0.48
CA2 P00918 12/20 0.44
CA1 P00915 11/20 0.44
CA9 Q16790 10/20 0.44
CA12 O43570 9/20 0.44
CA5A P35218 2/20 0.44
CA7 P43166 2/20 0.44
CA5B Q9Y2D0 2/20 0.44
CA3 P07451 1/20 0.44
CA6 P23280 1/20 0.44
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
PKM P14618 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15077326 0.85 HTT (0.50) HTTPOLBCA2CA1CA9
SCHEMBL26671266 0.82 CA2 (0.47) CA2CA1CA9CA12CA5A
SCHEMBL7141496 0.81 CA2 (0.49) CA2CA1CA9CA12CA5A
SCHEMBL7911297 0.80 POLB (0.43) HTTPOLBCA2CA1CA9
SCHEMBL7914247 0.79 POLB (0.46) HTTPOLBCA2CA1CA9
SCHEMBL7139259 0.78 GAA (0.49) POLBCA2CA1CA9CA12
SCHEMBL6669968 0.75 CA2 (0.55) HTTPOLBCA2CA1CA9
SCHEMBL29365636 0.74 LMNA (0.61) HTTPOLBCA2CA1CA9
SCHEMBL233320 0.74 LMNA (0.61) HTTPOLBCA2CA1CA9
SCHEMBL20885022 0.74 CA1 (0.49) HTTCA2CA1CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1127479-C Sulfonylurea derivatives and their use in the control of interleukin-1 activity PFIZER (US) 2003-11-12 CN disclosed
EP-0964849-B1 SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY PFIZER (US) 2003-06-04 EP disclosed
EP-1270565-A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives PFIZER INC. (US) 2003-01-02 EP disclosed
EP-1270554-A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC. (US) 2003-01-02 EP disclosed
US-6433009-B1 TREATMENT OF AUTOIMMUNE, CARDIOVASCULAR, NERVOUS SYSTEM, GASTROINTESTINAL, RESPIRATORY SYSTEM, AND VIRAL DISORDERS; ANTIDIABETIC, ANTIARTHRITIC, ANTIINFLAMMATORY AND ANTIDEPRESSANT AGENTS PFIZER INC 2002-08-13 US disclosed
EP-1214087-A1 COMBINATION TREATMENT WITH IL-1RA AND COMPOUNDS THAT INHIBIT IL-1 PROCESSING AND RELEASE Pfizer Products Inc. (US) 2002-06-19 EP disclosed
WO-2001019390-A1 COMBINATION TREATMENT WITH IL-1RA AND DIARYL SULPHONYL UREA COMPOUNDS PFIZER PRODUCTS INC. (US) 2001-03-22 WO disclosed
US-6166064-A Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC (US) 2000-12-26 US disclosed
CN-1245490-A Sulfonyl urea derivatives and their use in control of interleukin-1 activity PFIZER (US) 2000-02-23 CN disclosed